The Role of AIM2 in Cancer Development
Author Information
Author(s): Sui Lina, Xi Yuling, Zheng Siping, Xiao Qiuxiang, Liu Zhiping
Primary Institution: Gannan Medical University
Hypothesis
AIM2 plays a significant role in the pathogenesis of various cancers through both inflammasome-dependent and inflammasome-independent mechanisms.
Conclusion
AIM2 has diverse functions in cancer development, exhibiting both anti-tumor and pro-tumor effects depending on the cancer type and context.
Supporting Evidence
- AIM2 can trigger inflammasome activation, leading to the release of pro-inflammatory cytokines.
- Reduced AIM2 expression is linked to poor prognosis in several cancer types.
- AIM2 has been shown to inhibit cancer cell proliferation and induce apoptosis in various cancers.
- AIM2's role can vary significantly, sometimes promoting cancer progression in specific contexts.
Takeaway
AIM2 is a protein that helps our body fight infections and can also affect how cancer grows, sometimes helping to stop it and other times helping it grow.
Methodology
This review summarizes recent research on AIM2's role in various cancers, focusing on its mechanisms of action.
Limitations
The variability of AIM2's effects across different cancer types and the challenges in targeting it therapeutically.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website